Why the study?
Does Transforming Growth Factor-β function blocking prevent myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats?
Does Transforming Growth Factor-β function blocking prevent myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats?
Blocking TGF-beta function may serve as a new therapeutic strategy to prevent myocardial fibrosis and diastolic dysfunction in pressure-overloaded hearts.
Answers are grounded in this paper and cite their sources.
TGF-β blockade shows promise against pressure-overload fibrosis; hypothesis-generating in rats and leaves open human translation.
TGF-beta plays a causal role in myocardial fibrosis and diastolic dysfunction through fibroblast activation in pressure-overloaded hearts. Our findings may provide an insight into a new therapeutic strategy to prevent myocardial fibrosis and diastolic dysfunction in pressure-overloaded hearts.
No takes yet. Share an insight, caveat, or question.
Kuwahara et al. (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: